ArticleBMC women's health2026
The interplay between premenstrual syndrome, eating disorder risk, and adiposity indicators: a cross-sectional study.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPremenstrual syndrome (PMS) can negatively affect the quality of life of women of childbearing age, and symptom severity may increase in relation to visceral adiposity. The visceral adiposity index (VAI) is a novel indicator of adipose tissue dysfunction and may be useful in assessing risks associated with PMS and obesity. This study aimed to determine the relationships between PMS, VAI, and eating attitudes in women.
methodsThis cross-sectional study was conducted with 252 female volunteers aged 18–40 years who applied to a Ministry of Health Healthy Nutrition and Active Life Unit in Istanbul, Türkiye. Data were collected using a sociodemographic information form, the Premenstrual Syndrome Scale (PMSS), the Eating Attitudes Test (EAT-26), and a retrospective 24-hour dietary recall. Anthropometric measurements (weight, height, waist circumference) were taken, body composition was determined via bioelectrical impedance analysis (BIA), and VAI was calculated. Mann-Whitney U, Chi-square, and Logistic Regression tests were used for statistical analyses.
resultsPMS was detected in 57.9% of participants. The PMS group showed a significantly higher body fat percentage (38.1% vs. 37.1%, p = 0.039) compared to non-PMS group. Although VAI levels did not differ significantly between the groups, regression analysis revealed that high BMI, rather than PMS status, was the primary independent risk factor for eating disorders.
conclusionThese findings specifically suggest that body fat percentage plays a more critical role than VAI in PMS symptomatology. While no significant differences in energy or nutrient intake were identified between groups in this study, the results highlight a significant interaction between PMS symptom severity and the risk of eating disorders. This suggests that weight management strategies encompassing both nutritional interventions and body composition targets should be prioritized for individuals with PMS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.